← FDA Drug Approvals (Drugs@FDA)

DOSTINEX

NDA · New Drug Application · Sponsor: PFIZER · Approved 1996-12-23

Drug application

FDA Application #

NDA020664

Application type

New Drug Application

Brand name

DOSTINEX

Generic name

CABERGOLINE

Active ingredients

CABERGOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PFIZER

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

1996-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown